Since 3-oxoLCA and isoLCA levels are reduced in patients with IBD and inversely correlated with Th17 cell/IL-17-related genes, decreased 3-oxoLCA and isoLCA in dysbiosis could contribute to IBD pathophysiology (Paik et al. 2022). The gene discussed is IL17A; the disease is inflammatory bowel disease.